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Abstract
Background: Allergic contact dermatitis is a common disorder in adults and children alike and appears to be on the
increase. The purpose of this study was to determine the sensitization trends in Iranian children with contact dermatitis.
Methods: The result of 109 patch tests performed using the 24 allergens of the European Standard Series in patients
below 18 years old from September 2007 to March 2009 were recorded and analyzed. The tests were evaluated at 48
and 72 h after performing.
Results: The study population consisted of 72 (66.1 %) females and 37 (33.9 %) males. Hands were the most commonly
affected anatomic site. In the final evaluation of the tests on day three, 51 (46.8 %) individuals showed a positive reaction
to at least one allergen. Females were significantly more likely to show a positive response to at least one allergen
(p-value = 0.031, odds ratio: 2.46). The most common allergens were nickel sulfate, cobalt, methylisothiazolinone, and
colophony with 21 (19.3 %), 11 (10.1 %), 7 (6.4 %), and 6 (5.5 %) positive reactions, respectively. Contact allergy to nickel
sulfate was more common in females than males (23.6 % vs. 10.8 %). There was no statistically significant relationship
between personal or family history of atopy and a positive reaction to patch testing. The clinical and practical relevance
were assessed for nickel and cobalt with a clinical current relevance in 11 (52.3 %) and 4 (36.4 %), respectively.
Conclusions: Nickel sulfate, cobalt, methylisothiazolinone, and colophony are the most common allergens responsible for
induction of allergic contact dermatitis in Iranian children and adolescents. Females tended to show more positive
reactions to allergens.
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Background
Allergic contact dermatitis (ACD) is an inflammatory
skin disease caused by a T-cell-mediated delayed-type
hypersensitivity reaction [1]. In ACD, the hapten is ini-
tially introduced to the epidermal langerhans cells.
These cells migrate to the regional lymph nodes and the
allergen is subsequently processed by the T-lymphocytes.
Upon re-exposure of the allergen, CD8+ T-cells response
is mediated by the CD4+ T-cell subset [2].
ACD affects up to 20 % of the pediatric population
[3]. According to previous studies, 14.5 to 70.7 % of
children with a clinical diagnosis of contact dermatitis
have positive reactions to one of the applied allergens
for patch testing [4, 5]. Based on a recent review of five
patch test studies in children, the most commonly
reported allergens in children are neomycin, balsam of
Peru, fragrance mix, lanolin, cocamidopropylbetaine, for-
maldehyde, corticosteroids, methylchlorisothiazolinone/
methylisothiazolinone, propylene glycol, and benzalko-
nium chloride [6]. Properly performed and interpreted
patch testing is the gold standard for identification and
documentation of allergic sensitization and its inducing
agents in children and adults [7, 8]. Although patch test-
ing in children is not approved by the FDA, it has proven
to be a safe procedure both in adults and children [9].
There are no rules and limitations for patch testing in
children in Iran. Therefore, we often use it on similar ap-
proved indication for adults.
The purpose of this study was to determine the causes
of allergic contact dermatitis and identify the pattern of
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allergen responsiveness in Iranian children and adoles-
cents affected by ACD.
Methods
The study was approved by Tehran University of Med-
ical Scienced board of ethics. Registered data of 109
patch tests performed in individuals younger than
18 years old diagnosed clinically and/or histopathologic-
ally with allergic contact dermatitis and referred by
dermatologists for patch testing were collected and
analyzed. We used the ESS (European Standard Series
Hermal, Reinbek, Germany) at similar allergen concen-
trations as for adults. The allergens were applied on the
healthy skin of the patients’ backs and left for 48 h. Read-
ings were performed at 48 h, 72 h and after patch testing
(on day 2 and day 3). Reactions were classified and docu-
mented according to the criteria of the International
Contact Dermatitis Research Group (ICDRG) as follows:
(0 = negative), (+/− = doubtful), (+ = erythema), (++ =
papule vesicle formation), and (+++ = bulla formation or ul-
ceration) [7].
Statistical analysis
Data management and descriptive statistical analysis were
performed using the SPSS 16 statistical program. Chi-
square and Fisher’s exact tests were used and a P-value
less than 0.05 was considered a statistically significant
difference.
Results
The study population consisted of 37 (33.9 %) males and
72 (66.1 %) females. The mean age was 14.4 with a
standard deviation of 3.4 years (range: 5–18 years). A
positive personal history of atopy was recorded in 48 pa-
tients (44.0 %). Forty one (37.6 %) had a positive family
history of atopy. Anatomic sites of involvement in order
of frequency are shown in Table 1. Hands were the most
common site of involvement (Additional files 1 and 2).
Results of patch test reading on day 2 and re-evaluation
on day 3 (72 h) with regard to one or more reaction to al-
lergens or negative or doubtful results in male and female
patients are shown in Table 2.
Females were significantly more likely to show a posi-
tive response to at least one allergen (p-value = 0.031,
odds ratio: 2.46, 95 %, and confidence interval (CI):
1.07–5.64). We found no significant difference in the
frequency of positive patch test responses among pa-
tients with and without personal or family history of
atopy (Table 3).
The overall results of patch test reading on day 2 and
re-evaluation on day 3 based on gender are shown in
Table 4. The ten most common inciting allergen in our
series were nickel sulfate (21,19.3 %), cobalt chloride
(11,10.1 %), methylisothiazolinone (7,6.4 %), colophony
(6,5.5 %), potassium dichromate (5,4.6 %), paraben mix
(4,3.7 %), 4-tert-butylphenon (4,3.7 %), fragrance mix
(4,3.7 %), thiuram mix (3,2.8 %), mercapto mix (3,2.8 %),
4-phenylendiamine base (2,1.8 %), and formaldehyde
(2,1.8 %) (Additional file 2).
Positive allergic reaction to nickel was more common
in females than in males, however, without statistical sig-
nificance (23.6 % vs. 10.8 %, p-value = 0.130) (Table 4).
We could only assess the clinical and practical relevance
in the two most important allergens (nickel and cobalt),
and we observed clinical current relevance in 11 (52.3 %)
and 4 (36.4 %) for nickel and cobalt, respectively.
Results of patch test reading according to age groups
are shown in Table 5.
For most allergens (except cobalt chloride, methyli-
sothiazolinone, paraben mix, and fragrance mix), the
percentages of positive response in the older age group
(11–18 years) were higher than children below 10 years.
The most common allergen in the younger age group
were cobalt chloride (4, 18.2 %), nickel sulfate (3, 13.6 %),
methylisothiazolinone (2, 9.1 %), and paraben mix (2, 9.1 %)
while in the older group they were as follows: nickel sulfate,
cobalt chloride, methylisothiazolinone, colophony, potas-
sium dichromate.
Discussion
In this study we have identified the inciting allergen ac-
cording to patch tests in 109 children with ACD. Con-
tact dermatitis in children has been studied less
extensively than adults in the existing literature [10, 11].
In the current study, overall 48.6 % of patients had
one or more positive patch test results. The positive re-
sponse rate to patch test allergens ranges from 15 to
62.3 % in different studies [5, 12, 13].
Nickel was the most common allergen in our study, a
common finding with most previous reports [10, 14, 15].
Although some authors have reported the rate of false-
positive and irritant reactions to nickel is higher among
Table 1 Anatomic sites of involvement in order of frequency
Anatomic sites of involvement Frequency
Hand 84 (77.1 %)
Face 30 (27.5 %)
Calf 23 (21.1 %)
Foot 17 (15.6 %)
Back 9 (8.2 %)
Forearm 9 (8.2 %)
Abdomen 8 (8.7 %)
Knee 7 (7.6 %)
Thorax 7 (7.6 %)
Arm 6 (6.5 %)
Body 6 (6.5 %)
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children [16], other studies suggest that this high rate
might be due to use of adult concentration of allergen
for patch testing [17], and the recent series do not con-
firm this [6]. We could not demonstrate clinical rele-
vance in about half of the cases in our study. In our
series nickel sulfate, cobalt chloride, methylisothiazoli-
none, colophony, potassium dichromate, paraben mix,
4-tert-butylphenon, fragrance mix, thiuram mix, mer-
capto mix, phenylendiamine base, and formaldehyde
were the most common allergens in decreasing order of
frequency.
The most commonly reported allergens in a study in
Singapore were Nickel (40 %), Thimerosal (15 %), Col-
ophony (9 %), Lanolin (8 %), Cobalt (8 %), Fragrance
mix (5 %), and Neomycin (4 %) [18]. While in another
study in Turkey, the most commonly documented incit-
ing allergens were Nickel sulfate (46 %), Cobalt chloride
(9.5 %), p-Phenylenediamine (9.5 %), Neomycin sulfate
20 % (7 %), Formaldehyde 1 % (4.6 %), Fragrance mix
8 % (3.9 %), CL-methylisothiazolinone 0.01 % (3.1 %),
Mercapto mix 2 % (3.1 %), Quaternium 15 % (2.3 %),
Benzocaine 5 % (2.3 %), and Potassium dichromate 0.5 %
(1.5 %) [19]. In a recent review of five pediatric patch test
studies to, the top ten allergens were neomycin, balsam of
Peru, fragrance mix, lanolin, cocamidopropylbetaine,
formaldehyde, corticosteroids, methylchlorisothiazolinone/
methylisothiazolinone, propylene glycol, and benzalkonium
chloride [6]. The observed differences in the frequency of
the allergens responsible for induction of ACD between the
present study and other studies may be explained by a var-
iety of reasons. First and foremost, the prevalence of sensi-
tivity to an individual allergen depends not only on the
intrinsic allergenicity of the compound but also on the level
of allergen exposure to the population, which may vary
from country to country [20–23]. Another important issue
is that investigators often employ a variety of test panels
and allergen concentrations in different studies, therefore
rendering comparisons difficult [23]. There are disagree-
ments as to whether there is seasonal and temporal vari-
ation in reactivity to allergens [24]. Moreover, reactivity to
some allergens may be influenced by ethnic factors [25].
Gender differences in rates of reactions to a variety of
contact allergens have been previously reported [2, 5]. In
our study females were significantly more likely to have
positive tests. This finding is consistent with previously
published studies [5, 12, 15]. Nevertheless, in one study
no difference between sex and reactivity to the applied
allergens was observed [26].
In the current study, nickel sensitivity was also found
to be more frequent in females; however, without statis-
tical significance (Table 4). Ear piercing has been consid-
ered as the most common cause of nickel sensitization
and the reason for its higher rate in females, with the
risk of nickel allergy rising with the number of piercings
[12]. Piercing is a common tradition in Iran and is usu-
ally performed in girls early in life often followed by long
term wearing of golden earing to keep the hole open.
Low-carat gold may contain nickel [19] In contrast to
studies reporting more potassium dichromate reactivity
in adult males, we found no male predominance for this
allergen [27, 28].
As previously reported, co-reactivity between cobalt
and nickel allergy was observed in our study [2, 18]. We
found that in 45.5 % of patients with positive cobalt re-
sponses nickel reactivity was also present, while 23.8 %
of patients with positive patch tests to nickel also had
positive reaction to cobalt. In agreement with our re-
sults, Rystedt reported that nickel sensitivity predisposed
the patients to cobalt sensitivity [29].
Our results showed that older children tend to show
more positive reactions to allergens. This finding is in
concordance with a pervious study that showed the rate
of patch test positivity was higher in older age groups
[12]. Moreover, it should be taken into account that
Table 2 The overall positive, doubtful and negative responses to patch test allergens among male and female patients
Gender Positive Percent Negative Percent Doubtful Percent
Male (N = 37) 12 32.4 12 32.4 13 35.2
Female (N = 72) 39 54.2 25 34.7 8 11.1
Total (N = 109) 51 46.8 37 33.9 21 19.3
Table 3 Comparison of reactions to allergens (at least one positive or negative reaction) in patients with or without personal or
family history of atopy
Total Reaction to allergens p-value
Positive (one or more reactions) Negative
personal history of atopy + 48 26 (54.2 %) 22 (45.8 %) 0.171
- 61 25 (41.0 %) 36 (59.0 %)
family history of atopy + 41 23 (56.1 %) 18 (43.9 %) 0.130
- 68 28 (41.2 %) 40 (58.8 %)
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contact dermatitis increases with age and is more com-
mon in older individuals [30]. However, according to
some researchers an age-dependent decrease in delayed
type hypersensitivity may occur with age [30].
In the present study 44.0 % of patients had a personal
history of atopy. The relationship between atopy and ACD
remains controversial [31, 32]. Although it has been as-
sumed that atopy could be a predisposing factor for the
development of ACD, and more reactivity to specific aller-
gens have been reported in atopic patient [33–35]; we
found no significant association between personal or fam-
ily history of atopy and patch test results. In concordance
with our findings, some studies indicate that there is a
similar prevalence of ACD in individuals with and without
atopic diathesis [31, 36]. Hands were the most frequent
sites of ACD in our study. Metal preservative and rubber
are the most common causes for ACD of this region [11].
Also, in our study metal was the most common causative
allergens of ACD.
In the present study, the face was the second most fre-
quent ACD anatomic site. In some studies, the face was
the most common site of ACD in children and adoles-
cents [11].
Positive clinical relevance of the positive reactions was
considered if the patient described a current or past cuta-
neous exposure to a product known to contain the aller-
gen to which the patient reacted [7]. For some allergens in
the pediatric patient group evaluation of relevance was
not possible due to unknown history of exposure.
Methylisothiazolinone is a common preservative found
in many cosmetic and toiletry products marketed to
both children and adults. It is increasingly known to
cause ACD, especially in perioral and perineal regions
due to facial or baby wipes [37]. Colophony is a cause of
ACD to adhesives and tapes. However, the clinical rele-
vance of a positive patch-test reaction to colophony is
often difficult to evaluate [38].
Our study is limited by small sample size, also we were
unable to evaluate the relevance for positive patch test
for all antigens. Studies with greater sample size and
with adequate antigen relevance determination is recom-
mended in Iranian children with ACD.
Table 4 Positive response to allergens of the European standard series in Iranian children with allergic contact dermatitis







Nickel sulfate 5 21 19.3 4 10.8 17 23.6 0.130 11 (52.3 %)
Cobalt chloride 1 11 10.1 5 13.5 6 8.3 0.504 4 (36.4 %)
Methylisothiazolinone 0.05 7 6.4 1 2.7 6 8.3 0.419 NA
Colophony 20 6 5.5 1 2.7 5 6.9 0.662 NA
Potassium dichromate 0.5 5 4.6 3 8.1 2 2.8 0.334 NA
Paraben mix 16 4 3.7 2 5.4 2 2.8 0.603 NA
4-tert-butylphenol formaldehyde resin 1 4 3.7 0 0.0 4 5.6 0.297 NA
Fragrance mix 8 4 3.7 1 2.7 3 4.2 1.000 NA
Thiuram mix 1 3 2.8 1 2.7 2 2.8 1.000 NA
Mercapto mix 1 3 2.8 0 0.0 3 4.2 0.550 NA
4-Phenylenediamine base 1 2 1.8 0 0.0 2 2.8 0.547 NA
Formaldehyde 1 2 1.8 1 2.7 1 1.4 1.000 NA
N-isopropyl-N-phenyl-4-phenylenediamine 0.1 2 1.8 1 2.7 1 1.4 1.000 NA
Wool Alcohol 30 2 1.8 0 0.0 2 2.8 0.547 NA
Sesquiterpene lactone mix 0.1 2 1.8 2 5.4 0 0.0 0.113 NA
Benzocaine 5 2 1.8 0 0.0 2 2.8 0.547 NA
Cliquinol 5 1 0.9 1 2.7 0 0.0 0.339 NA
Balsam of peru 25 1 0.9 0 0.0 1 1.4 1.000 NA
Epoxy resin 1 1 0.9 0 0.0 1 1.4 1.000 NA
Quaterium-15 1 1 0.9 0 0.0 1 1.4 1.000 NA
Mercaptobenzothiazole 2 1 0.9 1 2.7 0 0.0 0.339 NA
Neomycin sulphate 20 1 0.9 0 0.0 1 1.4 1.000 NA
Hydroxyl-methyl-penthyl-cyclo-carboxaldehyde 5 1 0.9 1 2.7 0 0.0 0.339 NA
Primin 0.01 0 0.0 0 0.0 0 0.0 NA NA
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Conclusion
Our results indicate that nickel sulfate, cobalt, methyli-
sothiazolinone, and colophony are the most common al-
lergens responsible for induction of allergic contact
dermatitis in Iranian children and adolescents. Females
tend to show more positive reactions to allergens. These
findings are crucial in the treatment, long term manage-
ment, and proper education of children with allergic
contact dermatitis.
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